Charles Schwab Investment Management Inc. Boosts Stake in Semler Scientific, Inc. (NASDAQ:SMLR)

Charles Schwab Investment Management Inc. raised its position in Semler Scientific, Inc. (NASDAQ:SMLR) by 11.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 48,625 shares of the company’s stock after buying an additional 4,802 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Semler Scientific were worth $2,626,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of SMLR. Victory Capital Management Inc. increased its position in Semler Scientific by 202.2% during the 3rd quarter. Victory Capital Management Inc. now owns 19,298 shares of the company’s stock worth $454,000 after purchasing an additional 12,912 shares in the last quarter. Quest Partners LLC increased its position in shares of Semler Scientific by 48.0% in the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock worth $59,000 after acquiring an additional 817 shares in the last quarter. Crawford Fund Management LLC purchased a new position in shares of Semler Scientific in the 3rd quarter valued at $883,000. Verition Fund Management LLC acquired a new position in shares of Semler Scientific during the 3rd quarter valued at $251,000. Finally, State Street Corp boosted its position in Semler Scientific by 0.6% during the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after purchasing an additional 725 shares during the period. 49.37% of the stock is owned by institutional investors and hedge funds.

Semler Scientific Stock Performance

Semler Scientific stock opened at $36.92 on Friday. The firm has a market capitalization of $354.32 million, a PE ratio of 7.52 and a beta of 1.33. Semler Scientific, Inc. has a one year low of $20.88 and a one year high of $81.56. The stock’s 50 day moving average price is $46.02 and its 200 day moving average price is $44.53.

Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The business had revenue of $12.41 million for the quarter.

Wall Street Analyst Weigh In

Separately, Lake Street Capital raised their price objective on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research report on Friday, January 24th.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.